Short CV/Education and training

  • 1986 – 1991
    Studies in biochemistry Freie Universität Berlin, Germany

  • 1991 – 1994
    PhD, Freie Universität Berlin, Germany Structural Biology and Biochemistry

  • 1994 – 1998
    Post-Doc, California Institute of Technology, Pasadena, CA, USA

  • 1998 – 2001
    Assistant Professor Stony Brook University, Stony Brook, NY, USA

  • 2001 – 2005
    Associate Professor Stony Brook University, Stony Brook, NY, USA

  • Since 2005
    Professor, Rudolf Virchow Center for Experimental Biomedicine, University of Würzburg

  • Since 2009
    Dean Graduate School of Life Sciences, University of Würzburg

  • Since 2009
    Vice-Chair Rudolf Virchow Center for Experimental Biomedicine

Membership in scientific bodies/juries

  • 2007 – 2012 Vice Chair Structural Biology Section of the German Society for Biochemistry and Molecular Biology

  • Since 2002 Editorial Board DNA repair


You can only see the contact information of the academics in the database if you are a registered user of AcademiaNet.
Please register here


  1. Read what our members say about AcademiaNet.

No more excuses!

  1. Please download the brochure "No more excuses" and read more about female experts in Europe, and about AcademiaNet.

Similar profiles

  1. Dr. Cristina Afonso

    Physical sciences

  2. Dr. Fatemeh Ajalloueian

    Physical sciencesBiopolymers, Fiber science

  3. Prof. Dr. Conny Aerts

    Physical sciencesAsteroseismology

  4. Prof. Dr. Amparo Acker-Palmer

    Biological and related sciences , HealthCell Biology, Cellular and Molecular Neuroscience, Vascular Biology, Tumour Biology



  1. New Approach to Fight Tuberculosis

    Caroline Kisker's research team from Würzburg, together with colleagues form Stony Brook University, have found a new weak spot in the bacterium that causes tuberculosis: blocking a specific enzyme involved in the cholesterol catabolism.

  2. Weakness of a Dangerous Hospital Bacterium

    When discussing the dangers of antibiotic-resistant bacteria in hospitals, the name Staphylococcus aureus will almost certainly be mentioned. In search of new agents against this bacterium, one of the main targets is the enzyme FabI. It has now been characterized in detail by scientists from the Rudolf Virchow Center in Würzburg. They also found indications why Staphylococcus aureus is more susceptible to the blockage of this enzyme than other bacteria.

  3. New Agents to Combat the Plague

    The plague is believed to have been eradicated in Europe. But it continues to reappear in other parts of the world. Since the pathogens are becoming resistant to the usual antibiotics, new agents are urgently needed. Progress has now been made.